General Information of the Compound
Compound ID |
CP0432083
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
2-benzyl-3-(4-methylpiperazin-1-yl)quinoxaline
Show/Hide
|
||||||||||||||||||
Synonyms |
1001065-53-7
3-Benzyl-2-(4-methylpiperazinyl)-quinoxaline
AKOS016340709
BDBM50412496
CHEMBL261551
KS-00002WX1
MG-0235
MolPort-027-564-855
PQQUQVYOCGJWAX-UHFFFAOYSA-N
SCHEMBL602972
VUF 10148
VUF-10148
ZINC29054164
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C20H22N4
|
||||||||||||||||||
Molecular Weight |
318.424
|
||||||||||||||||||
Canonical SMILES |
CN1CCN(CC1)c1nc2ccccc2nc1Cc1ccccc1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C20H22N4/c1-23-11-13-24(14-12-23)20-19(15-16-7-3-2-4-8-16)21-17-9-5-6-10-18(17)22-20/h2-10H,11-15H2,1H3
Show/Hide
|
||||||||||||||||||
InChIKey |
PQQUQVYOCGJWAX-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01206, Histamine H1 receptor
Protein ID: PT01711, Histamine H4 receptor
Clinical Information about the Compound